Related Experiment Videos

[Complex hemodynamic analysis of left ventricular systole in hypertrophic cardiopathy--clinical implications]

M Dabrowski1, B Górecka, A Witkowski

  • 1Kliniki Kardiologii Ogólnej i II Samodzielnej Pracowni Hemodynamiki Insytutu Kardiologii w Warszawie.

Kardiologia Polska
|January 1, 1990
PubMed

Insights

Hypertrophic cardiomyopathy patients show reduced left ventricular contractility and mechanical performance. Verapamil did not significantly improve contractility but may offer diastolic benefits.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Medical Imaging

Context:

  • Hypertrophic cardiomyopathy (HCM) involves complex hemodynamic disturbances affecting left ventricular (LV) systolic and diastolic function.
  • These functional impairments are often linked to underlying abnormalities in myocardial structure.
  • Understanding these relationships is crucial for managing HCM patients.

Purpose:

  • To assess left ventricular (LV) sufficiency and contractility in patients with hypertrophic cardiomyopathy.
  • To investigate the relationship between hemodynamic disturbances and the clinical status of HCM patients.
  • To evaluate the influence of verapamil on LV function and hemodynamic parameters.

Summary:

  • Hemodynamic assessment revealed decreased LV contractility (Vmax, power/volume) and mechanical performance (ejection volume, net work) in HCM patients.
  • Verapamil administration showed no significant improvement in LV contractility or mechanical performance.
  • Circumferential fiber shortening velocity (VCF) decreased, potentially due to increased afterload from altered ventricular kinetics.

Impact:

  • Findings suggest that myocardial hypertrophy in HCM may compensate for decreased myocardial sufficiency.
  • The study highlights a lack of negative impact of verapamil on LV contractility in this cohort.
  • Verapamil's potential beneficial effects on diastolic function warrant further investigation in HCM.

Related Concept Videos